Treatment of Primary Sjögren Syndrome With Rituximab

2014430 citationsJournal Article

Authors

Valérie Devauchelle‐Pensec · Centre Hospitalier Universitaire de Nantes

Xavier Mariette · Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale

Sandrine Jousse‐Joulin · Centre Hospitalier Universitaire de Nantes

Jean‐Marie Berthelot · Université Paris-Sud

Aleth Perdriger · Centre Hospitalier Universitaire de Rennes

Xavier Puéchal · Centre Hospitalier Universitaire de Nantes

Abstract

Rituximab did not alleviate symptoms or disease activity in patients with pSS at week 24, although it alleviated some symptoms at earlier time points.

Topics & Keywords

Salivary Gland Disorders and Functions Systemic Lupus Erythematosus Research Salivary Gland Tumors Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Internal Medicine

Volume 160, Issue 4, pp. 233-242

DOI: 10.7326/m13-1085

Field-Weighted Citation Impact: 21.92